The Impact of COVID-19 is included in Preclinical In-Vivo Imaging Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Preclinical In-Vivo Imaging Trends and Forecast
The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Preclinical In-Vivo Imaging by Segment
The study includes a forecast for the global preclinical in-vivo imaging by type, modality, application, distribution channel, and region.
Preclinical In-Vivo Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Optical Imaging
• Nuclear Imaging
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents
Preclinical In-Vivo Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:
• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
Preclinical In-Vivo Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Research & Development
• Drug Discovery
Preclinical In-Vivo Imaging Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Others
Preclinical In-Vivo Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Preclinical In-Vivo Imaging Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preclinical in-vivo imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-
• Bruker Corporation
• Siemens
• Trifoil Imaging
• Perkinelmer
• Visualsonics
Preclinical In-Vivo Imaging Market Insights
Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.
Within this market, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.
North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.
Features of the Global Preclinical In-Vivo Imaging Market
Market Size Estimates: Preclinical in-vivo imaging market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel and region in terms of ($B).
Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preclinical in-vivo imaging market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the preclinical in-vivo imaging market size?
Answer: The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030.
Q.2 What is the growth forecast for preclinical in-vivo imaging market?
Answer: The global preclinical in-vivo imaging market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the preclinical in-vivo imaging market?
Answer: The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.
Q4. What are the major segments for preclinical in-vivo imaging market?
Answer: The future of the preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets.
Q5. Who are the key preclinical in-vivo imaging market companies?
Answer: Some of the key preclinical in-vivo imaging companies are as follows:
• Bruker Corporation
• Siemens
• TriFoil Imaging
• PerkinElmer
• VisualSonics
Q6. Which preclinical in-vivo imaging market segment will be the largest in future?
Answer: Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.
Q7. In preclinical in-vivo imaging market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to preclinical in-vivo imaging market or related to preclinical in-vivo imaging companies, preclinical in-vivo imaging market size, preclinical in-vivo imaging cable market share, preclinical in-vivo imaging market growth, preclinical in-vivo imaging market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Preclinical In-Vivo Imaging Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Preclinical In-Vivo Imaging Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Preclinical In-Vivo Imaging Market by Type
3.3.1: Optical Imaging
3.3.2: Nuclear Imaging
3.3.3: MRI Contrast Agents
3.3.4: Ultrasound Contrast Agents
3.3.5: CT Contrast Agents
3.4: Global Preclinical In-Vivo Imaging Market by Modality
3.4.1: Optical Imaging Systems
3.4.2: Preclinical Nuclear Imaging Systems
3.4.3: Micro-MRI Systems
3.4.4: Micro-Ultrasound Systems
3.4.5: Micro-CT Systems
3.4.6: Preclinical Photoacoustic Imaging Systems
3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
3.5: Global Preclinical In-Vivo Imaging Market by Application
3.5.1: Research & Development
3.5.2: Drug Discovery
3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
3.6.1: Pharmaceutical Companies
3.6.2: Biotechnology Companies
3.6.3: Research Institutes
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Preclinical In-Vivo Imaging Market by Region
4.2: North American Preclinical In-Vivo Imaging Market
4.2.1: North American Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
4.2.2: North American Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
4.3: European Preclinical In-Vivo Imaging Market
4.3.1: European Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
4.3.2: European Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
4.4: APAC Preclinical In-Vivo Imaging Market
4.4.1: APAC Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
4.4.2: APAC Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
4.5: ROW Preclinical In-Vivo Imaging Market
4.5.1: ROW Preclinical In-Vivo Imaging Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
4.5.2: ROW Preclinical In-Vivo Imaging Market by Application: Research & Development and Drug Discovery
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bruker Corporation
7.2: Siemens
7.3: TriFoil Imaging
7.4: PerkinElmer
7.5: VisualSonics
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Preclinical In-Vivo Imaging Market Report.